Evidence map›Paper›PMID 41283131›Full record

ReviewIndian journal of surgical oncology2025

Risk Factors for Tumor Recurrence in Meningiomas: Multicenter Multivariate Analysis.

Daniel Alejandro Vega-Moreno, Gervith Reyes-Soto, Monica Serrano-Murillo, Manuel de Jesúes Encarnación-Ramírez, Ulises García-González, Bipin Chaurasia

Abstract readReview
In one paragraph

Review in Indian journal of surgical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Daniel Alejandro Vega-MorenoNeuro-Oncology Unit, Instituto Nacional de Cancerología, Avenida San Fernando 22, Belisario Domínguez Sección 16, 14090 TlalpanCiudad de Mexico, Mexico.
Gervith Reyes-SotoNeuro-Oncology Unit, Instituto Nacional de Cancerología, Avenida San Fernando 22, Belisario Domínguez Sección 16, 14090 TlalpanCiudad de Mexico, Mexico.
Monica Serrano-MurilloNeuro-Oncology Unit, Instituto Nacional de Cancerología, Avenida San Fernando 22, Belisario Domínguez Sección 16, 14090 TlalpanCiudad de Mexico, Mexico.
Manuel de Jesúes Encarnación-RamírezNeurological Surgery, Russian People's Friendship University, Moscow, Russia.
Ulises García-GonzálezNeurosurgery Department, Hospital Central Sur de Alta Especialidad, PEMEX, Ciudad de Mexico, Mexico.
Bipin ChaurasiaDepartment of Neurosurgery, Neurosurgery Clinic, Birgunj, Nepal.ORCID 0000-0002-8392-2072

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Meningiomas are among the most frequent primary brain tumors, so knowing the association of different factors with the imaging recurrence of meningiomas is important for post-surgical decision-making. We conducted a retrospective analysis in six high specialty hospitals in Mexico with 190 patients diagnosed with meningiomas and who underwent resection surgery from 2009 to 2019. A univariate and multivariate analysis was performed to identify different risk factors, a simple linear regression analysis for quantitative variables, and a comparison of means to identify the impact of the different factors with the months of survival free of tumor recurrence. A total of 190 patients were analyzed, with an overall recurrence rate of 38.9% (74 patients). Regarding risk factors, the onset of intracranial hypertension syndrome was associated with a higher risk of tumor recurrence at follow-up. The simple linear regression analysis found that the greater the intraoperative bleeding, the lower the survival rate of tumor recurrence. In the comparison analysis of means, the intracranial hypertension syndrome and the petroclival location significantly reduced the months of free survival of the tumor recurrence. We report that a clinical presentation such as intracranial hypertension syndrome increases the risk of recurrence in meningiomas up to eight times more and that the greater the intraoperative bleeding, the lower the survival free of recurrence.

Indexed as

Intracranial hypertension syndromeMeningioma recurrenceRisk factors

Identifiers

PMID41283131
PMCPMC12630521

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.